The ventilator’s two vaporizers could deliver an anesthetic simultaneously, possibly causing low blood pressure, irregular breathing and a lowered heart rate. The discovery prompted a Class 1 recall of the devices.
Aestiva/5 7900 was initially approved by the FDA in April 2000.
Related Articles on Anesthesia:
CMS: Nurse Anesthetists to be Reimbursed for Pain Management Services
Saint Francis Hospital Honors Anesthesia Associates
9 Recently Acquired Anesthesia Practices
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.